Literature DB >> 30188540

FDA approves first single-dose antimalarial.

Mark Ratner.   

Abstract

Year:  2018        PMID： 30188540     DOI： 10.1038/nbt0918-785a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Tafenoquine Is a Promising Drug Candidate for the Treatment of Babesiosis.

Authors:  Mingming Liu; Shengwei Ji; Daisuke Kondoh; Eloiza May Galon; Jixu Li; Mizuki Tomihari; Masashi Yanagawa; Michihito Tagawa; Mami Adachi; Masahito Asada; Ikuo Igarashi; Aiko Iguchi; Xuenan Xuan
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.